Celldex Therapeutics Inc (CLDX) — Cash Flow Quality Index
Latest as of December 2010:
-0.27x
Celldex Therapeutics Inc (CLDX) has a Cash Flow Quality Index of -0.27x as of December 2010. Operating cash flow of $-6.01 Million is below net income of $22.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Celldex Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.27x
Operating CF / Net Income
Operating Cash Flow
$-6.01 Million
USD
Net Income
$22.66 Million
USD
Data as of
Dec 2010
Most recent filing
Annual Cash Flow Quality Index for Celldex Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Celldex Therapeutics Inc. For live market cap and the full company financial profile, see CLDX market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.